logo
ALLOIMMUNIZATION, MEMORY, AND THE INTERPRETATION OF CROSSMATCH RESULTS FOR RENAL TRANSPLANTATION
THE ROLE OF BETA-2 MICROGLOBULIN IN TEMPERATURE-SENSITIVE AND INTERFERON-γ-INDUCED EXOCYTOSIS OF HLA CLASS I MOLECULES
THE PROLONGATION OF CONCORDANT HAMSTER-TO-RAT CARDIAC XENOGRAFTS BY BREQUINAR SODIUM
EVIDENCE THAT LONG-TERM SURVIVAL OF CONCORDANT XENOGRAFTS IS ACHIEVED BY INHIBITION OF ANTISPECIES ANTIBODY PRODUCTION
THE EFFECTS OF γ-GLUTAMYLCYSTEINE ETHYL ESTER, A PRODRUG OF GLUTATHIONE, ON ISCHEMIA-REPERFUSION-INDUCED LIVER INJURY IN RATS
THE EFFECT OF PROSTAGLANDIN E1 ON HEART PRESERVATION
THE EFFECTS OF LONG-TERM GRAFT PRESERVATION AND PROSTAGLANDIN E1 ON INTRAOPERATIVE HEMODYNAMIC CHANGES IN LIVER TRANSPLANTATION
THE OUTCOME OF PREGNANCY FOLLOWING RENAL TRANSPLANTATION—THE EXPERIENCE OF A SINGLE CENTER
THE LONG-TERM EFFECTS OF PROPHYLACTIC OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY TRANSPLANTATION—A SINGLE-CENTER, PROSPECTIVE, RANDOMIZED STUDY
PLASMA FIBRONECTIN LEVELS DURING ACUTE REJECTION AND ACUTE TUBULAR NECROSIS IN RENAL TRANSPLANT PATIENTS
THE INFLUENCE OF INCREASED AGE AND AGE MATCHING ON GRAFT SURVIVAL AFTER FIRST CADAVERIC RENAL TRANSPLANTATION
QUALITY-OF-LIFE CHANGES AND PSYCHIATRIC AND NEUROCOGNITIVE OUTCOME AFTER HEART AND LIVER TRANSPLANTATION
INDUCTION OF VASCULAR ADHESION MOLECULES DURING REJECTION OF HUMAN CARDIAC ALLOGRAFTS
THE RELATIONSHIP OF SERUM IL-6 LEVELS TO ACUTE GRAFT-VERSUS-HOST DISEASE AND HEPATORENAL DISEASE AFTER HUMAN BONE MARROW TRANSPLANTATION
PRETRANSPLANT AND POSTTRANSPLANT ANTIBODIES IN HUMAN CORNEAL TRANSPLANTATION
COMPARISON OF DNA AMPLIFICATION AND IMMUNOFLUORESCENCE FOR DETECTING PNEUMOCYSTIS CARINII IN PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY
EVIDENCE THAT THE SYSTEMATIC ANALYSIS OF BILE CYTOLOGY PERMITS MONITORING OF HEPATIC ALLOGRAFT REJECTION
INDUCTION OF TRANSPLANTATION TOLERANCE IN ADULTS USING DONOR ANTIGEN AND ANTI-CD4 MONOCLONAL ANTIBODY
EVIDENCE THAT LONG-TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI-CD4 MONOCLONAL ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T CELLS
INDUCTION OF SPECIFIC TOLERANCE TO CLASS I-DISPARATE RENAL ALLOGRAFTS IN MINIATURE SWINE WITH CYCLOSPORINE
THROMBOXANE AUGMENTATION OF ALLOREACTIVE T CELL FUNCTION
EVIDENCE THAT INDEFINITE SURVIVAL OF SMALL BOWEL ALLOGRAFTS ACHIEVED BY A BRIEF COURSE OF CYCLOSPORINE OR FK506 IS NOT DUE TO SYSTEMIC HYPORESPONSIVENESS
REDUCTION OF DELAYED-TYPE HYPERSENSITIVITY BY THE INJECTION OF n-3 POLYUNSATURATED FATTY ACIDS IN MICE
MATURING THYMOCYTES IN ACCELERATED REJECTION OF CARDIAC ALLOGRAFTS IN PRESENSITIZED RATS
RESISTANCE AND SUSCEPTIBILITY OF NEURAL CELLS TO LYSIS BY CYTOTOXIC LYMPHOCYTES AND BY CYTOLYTIC GRANULES
THE SUPPRESSIVE EFFECT OF DEOXYSPERGUALIN ON THE DIFFERENTIATION OF HUMAN B LYMPHOCYTES MATURING INTO IMMUNOGLOBULIN-PRODUCING CELLS
THE TIME COURSE OF CELL-MEDIATED LYMPHOLYSIS IN RAT HEPATIC ALLOGRAFT RECIPIENTS PRETREATED WITH A SINGLE DONOR-SPECIFIC BLOOD TRANSFUSION
IMMUNOGENICITY OF MHC CLASS I ALLOANTIGENS EXPRESSED ON PARENCHYMAL CELLS IN THE HUMAN KIDNEY
THE EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON THE REGULATION OF ACTIVATION-INDUCED APOPTOTIC CELL DEATH IN THYMOCYTES
PERCUTANEOUS BIOPSY OF PANCREAS TRANSPLANTS
MARGINAL BENEFIT OF DONOR CORTICOSTEROID THERAPY IN PROLONGED LUNG ALLOGRAFT PRESERVATION
HERPES SIMPLEX VIRUS AND NEUTROPENIA FOLLOWING BONE MARROW TRANSPLANTATION
EXTENDED SURVIVAL OF MHC-IDENTICAL ALLOGENEIC ISLET GRAFTS IN DIABETIC BB RATS—THE EFFECT OF AN INTERLEUKIN 2 RECEPTOR-TARGETED IMMUNOTHERAPY
THE TRANSPLANTATION OF ENCAPSULATED ISLETS OF LANGERHANS INTO THE PERITONEAL CAVITY OF THE BIOBREEDING RAT
A COMPARISON OF INITIAL FLUSHING SOLUTIONS IN LIVER PRESERVATION
OXYGENATION OF THE HUMAN PANCREAS DURING PRESERVATION BY A TWO-LAYER (UNIVERSITY OF WISCONSIN SOLUTION/PERFLUOROCHEMICAL) COLD-STORAGE METHOD
MAINTENANCE OF LIVER ADENINE NUCLEOTIDES DURING COLD ISCHEMIA THE VALUE OF A HIGH-PH, HIGH-PK FLUSH
EVIDENCE THAT THE RISKS OF MISOPROSTOL OUTWEIGH ITS BENEFITS IN STABLE CYCLOSPORINETREATED RENAL ALLOGRAFT RECIPIENTS
THE IMPACT OF HLA MATCHING ON GRAFT SURVIVAL
THE LOW NUMBER OF NATURAL KILLER CELLS IN RENAL TRANSPLANT RECIPIENTS WITH DE NOVO MALIGNANCIES
ERRATUM